Latin American algorithm for treatment of relapsing-remitting multiple sclerosis using disease-modifying agents

OBJECTIVE: It is estimated that circa 50,000 individuals have relapsing-remitting multiple sclerosis in Latin America. European and North-American algorithms for the treatment of multiple sclerosis do not foresee our regional difficulties and the access of patients to treatment. METHODS: The Latin American Multiple Sclerosis Forum is an independent and supra-institutional group of experts that has assessed the latest scientific evidence regarding efficacy and safety of disease-modifying treatments. Accesses to treatment and pharmacovigilance programs for each of the eight countries represented at the Forum were also analyzed. RESULTS: A specific set of guidelines based upon evidence-based recommendations was designed for Latin America. Future perspectives of multiple sclerosis treatment were also discussed. CONCLUSIONS: The present paper translated an effort from representatives of eight countries discussing a matter that cannot be adapted to our region directly from purely European and North-American guidelines for treatment.

Bibliographic Details

Main Authors:	Finkelsztejn,Alessandro, Gabbai,Alberto Alain, Fragoso,Yara Dadalti, Carrá,Adriana, Macías-Islas,Miguel Angel, Arcega-Revilla,Raul, García-Bonitto,Juan, Oehninger-Gatti,Carlos Luis, Orozco-Escobar,Geraldine, Tarulla,Adriana, Vergara,Fernando, Vizcarra,Darwin
Format:	Digital revista
Language:	English
Published:	Academia Brasileira de Neurologia - ABNEURO 2012
Online Access:	http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2012001000009
Tags:	Add Tag No Tags, Be the first to tag this record!